Industry Research Reports
Home > Reports > Chemical & Material > Myostatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Myostatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 116 Pages
Report ld: 4504755
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Myostatin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
North American market for Myostatin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Myostatin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Myostatin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Myostatin include Bio-Techne, Prospec, NeoScientific, FUJIFILM Irvine Scientific, R&D Systems, Beta Lifescience, ACROBiosystems, Biohaven, RayBiotech, Sino Biological, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Myostatin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Myostatin by region & country, by Type, and by Application.
The Myostatin market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myostatin.
MARKET SEGMENTATION
By Company
- Bio-Techne
- Prospec
- NeoScientific
- FUJIFILM Irvine Scientific
- R&D Systems
- Beta Lifescience
- ACROBiosystems
- Biohaven
- RayBiotech
- Sino Biological
- BioVendor
- Cell Guidance Systems
- MerckMillipore
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Active
- Inactive
Segment by Application
- Gene Therapy
- Basic Scientific Research
- Treating Muscular Dystrophy
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Myostatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Myostatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Myostatin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Myostatin Product Introduction
1.2 Global Myostatin Market Size Forecast
1.2.1 Global Myostatin Sales Value (2020-2031)
1.2.2 Global Myostatin Sales Volume (2020-2031)
1.2.3 Global Myostatin Sales Price (2020-2031)
1.3 Myostatin Market Trends & Drivers
1.3.1 Myostatin Industry Trends
1.3.2 Myostatin Market Drivers & Opportunity
1.3.3 Myostatin Market Challenges
1.3.4 Myostatin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Myostatin Players Revenue Ranking (2024)
2.2 Global Myostatin Revenue by Company (2020-2025)
2.3 Global Myostatin Players Sales Volume Ranking (2024)
2.4 Global Myostatin Sales Volume by Company Players (2020-2025)
2.5 Global Myostatin Average Price by Company (2020-2025)
2.6 Key Manufacturers Myostatin Manufacturing Base and Headquarters
2.7 Key Manufacturers Myostatin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Myostatin
2.9 Myostatin Market Competitive Analysis
2.9.1 Myostatin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Myostatin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myostatin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Active
3.1.2 Inactive
3.2 Global Myostatin Sales Value by Type
3.2.1 Global Myostatin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Myostatin Sales Value, by Type (2020-2031)
3.2.3 Global Myostatin Sales Value, by Type (%) (2020-2031)
3.3 Global Myostatin Sales Volume by Type
3.3.1 Global Myostatin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Myostatin Sales Volume, by Type (2020-2031)
3.3.3 Global Myostatin Sales Volume, by Type (%) (2020-2031)
3.4 Global Myostatin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gene Therapy
4.1.2 Basic Scientific Research
4.1.3 Treating Muscular Dystrophy
4.1.4 Others
4.2 Global Myostatin Sales Value by Application
4.2.1 Global Myostatin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Myostatin Sales Value, by Application (2020-2031)
4.2.3 Global Myostatin Sales Value, by Application (%) (2020-2031)
4.3 Global Myostatin Sales Volume by Application
4.3.1 Global Myostatin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Myostatin Sales Volume, by Application (2020-2031)
4.3.3 Global Myostatin Sales Volume, by Application (%) (2020-2031)
4.4 Global Myostatin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Myostatin Sales Value by Region
5.1.1 Global Myostatin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Myostatin Sales Value by Region (2020-2025)
5.1.3 Global Myostatin Sales Value by Region (2026-2031)
5.1.4 Global Myostatin Sales Value by Region (%), (2020-2031)
5.2 Global Myostatin Sales Volume by Region
5.2.1 Global Myostatin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Myostatin Sales Volume by Region (2020-2025)
5.2.3 Global Myostatin Sales Volume by Region (2026-2031)
5.2.4 Global Myostatin Sales Volume by Region (%), (2020-2031)
5.3 Global Myostatin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Myostatin Sales Value, 2020-2031
5.4.2 North America Myostatin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Myostatin Sales Value, 2020-2031
5.5.2 Europe Myostatin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Myostatin Sales Value, 2020-2031
5.6.2 Asia Pacific Myostatin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Myostatin Sales Value, 2020-2031
5.7.2 South America Myostatin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Myostatin Sales Value, 2020-2031
5.8.2 Middle East & Africa Myostatin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Myostatin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Myostatin Sales Value and Sales Volume
6.2.1 Key Countries/Regions Myostatin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Myostatin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Myostatin Sales Value, 2020-2031
6.3.2 United States Myostatin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Myostatin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Myostatin Sales Value, 2020-2031
6.4.2 Europe Myostatin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Myostatin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Myostatin Sales Value, 2020-2031
6.5.2 China Myostatin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Myostatin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Myostatin Sales Value, 2020-2031
6.6.2 Japan Myostatin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Myostatin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Myostatin Sales Value, 2020-2031
6.7.2 South Korea Myostatin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Myostatin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Myostatin Sales Value, 2020-2031
6.8.2 Southeast Asia Myostatin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Myostatin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Myostatin Sales Value, 2020-2031
6.9.2 India Myostatin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Myostatin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Bio-Techne
7.1.1 Bio-Techne Company Information
7.1.2 Bio-Techne Introduction and Business Overview
7.1.3 Bio-Techne Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Bio-Techne Myostatin Product Offerings
7.1.5 Bio-Techne Recent Development
7.2 Prospec
7.2.1 Prospec Company Information
7.2.2 Prospec Introduction and Business Overview
7.2.3 Prospec Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Prospec Myostatin Product Offerings
7.2.5 Prospec Recent Development
7.3 NeoScientific
7.3.1 NeoScientific Company Information
7.3.2 NeoScientific Introduction and Business Overview
7.3.3 NeoScientific Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 NeoScientific Myostatin Product Offerings
7.3.5 NeoScientific Recent Development
7.4 FUJIFILM Irvine Scientific
7.4.1 FUJIFILM Irvine Scientific Company Information
7.4.2 FUJIFILM Irvine Scientific Introduction and Business Overview
7.4.3 FUJIFILM Irvine Scientific Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 FUJIFILM Irvine Scientific Myostatin Product Offerings
7.4.5 FUJIFILM Irvine Scientific Recent Development
7.5 R&D Systems
7.5.1 R&D Systems Company Information
7.5.2 R&D Systems Introduction and Business Overview
7.5.3 R&D Systems Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 R&D Systems Myostatin Product Offerings
7.5.5 R&D Systems Recent Development
7.6 Beta Lifescience
7.6.1 Beta Lifescience Company Information
7.6.2 Beta Lifescience Introduction and Business Overview
7.6.3 Beta Lifescience Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Beta Lifescience Myostatin Product Offerings
7.6.5 Beta Lifescience Recent Development
7.7 ACROBiosystems
7.7.1 ACROBiosystems Company Information
7.7.2 ACROBiosystems Introduction and Business Overview
7.7.3 ACROBiosystems Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 ACROBiosystems Myostatin Product Offerings
7.7.5 ACROBiosystems Recent Development
7.8 Biohaven
7.8.1 Biohaven Company Information
7.8.2 Biohaven Introduction and Business Overview
7.8.3 Biohaven Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Biohaven Myostatin Product Offerings
7.8.5 Biohaven Recent Development
7.9 RayBiotech
7.9.1 RayBiotech Company Information
7.9.2 RayBiotech Introduction and Business Overview
7.9.3 RayBiotech Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 RayBiotech Myostatin Product Offerings
7.9.5 RayBiotech Recent Development
7.10 Sino Biological
7.10.1 Sino Biological Company Information
7.10.2 Sino Biological Introduction and Business Overview
7.10.3 Sino Biological Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Sino Biological Myostatin Product Offerings
7.10.5 Sino Biological Recent Development
7.11 BioVendor
7.11.1 BioVendor Company Information
7.11.2 BioVendor Introduction and Business Overview
7.11.3 BioVendor Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 BioVendor Myostatin Product Offerings
7.11.5 BioVendor Recent Development
7.12 Cell Guidance Systems
7.12.1 Cell Guidance Systems Company Information
7.12.2 Cell Guidance Systems Introduction and Business Overview
7.12.3 Cell Guidance Systems Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Cell Guidance Systems Myostatin Product Offerings
7.12.5 Cell Guidance Systems Recent Development
7.13 MerckMillipore
7.13.1 MerckMillipore Company Information
7.13.2 MerckMillipore Introduction and Business Overview
7.13.3 MerckMillipore Myostatin Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 MerckMillipore Myostatin Product Offerings
7.13.5 MerckMillipore Recent Development
8 Industry Chain Analysis
8.1 Myostatin Industrial Chain
8.2 Myostatin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Myostatin Sales Model
8.5.2 Sales Channel
8.5.3 Myostatin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Myostatin Market Trends
Table 2. Myostatin Market Drivers & Opportunity
Table 3. Myostatin Market Challenges
Table 4. Myostatin Market Restraints
Table 5. Global Myostatin Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Myostatin Revenue Market Share by Company (2020-2025)
Table 7. Global Myostatin Sales Volume by Company (2020-2025) & (kg)
Table 8. Global Myostatin Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Myostatin Price by Company (2020-2025) & (US$/kg)
Table 10. Key Manufacturers Myostatin Manufacturing Base and Headquarters
Table 11. Key Manufacturers Myostatin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Myostatin
Table 13. Global Myostatin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myostatin as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Myostatin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Myostatin Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Myostatin Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Myostatin Sales Market Share in Value by Type (2020-2025)
Table 20. Global Myostatin Sales Market Share in Value by Type (2026-2031)
Table 21. Global Myostatin Sales Volume by Type: 2020 VS 2024 VS 2031 (kg)
Table 22. Global Myostatin Sales Volume by Type (2020-2025) & (kg)
Table 23. Global Myostatin Sales Volume by Type (2026-2031) & (kg)
Table 24. Global Myostatin Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Myostatin Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Myostatin Price by Type (2020-2025) & (US$/kg)
Table 27. Global Myostatin Price by Type (2026-2031) & (US$/kg)
Table 28. Global Myostatin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Myostatin Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Myostatin Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Myostatin Sales Market Share in Value by Application (2020-2025)
Table 32. Global Myostatin Sales Market Share in Value by Application (2026-2031)
Table 33. Global Myostatin Sales Volume by Application: 2020 VS 2024 VS 2031 (kg)
Table 34. Global Myostatin Sales Volume by Application (2020-2025) & (kg)
Table 35. Global Myostatin Sales Volume by Application (2026-2031) & (kg)
Table 36. Global Myostatin Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Myostatin Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Myostatin Price by Application (2020-2025) & (US$/kg)
Table 39. Global Myostatin Price by Application (2026-2031) & (US$/kg)
Table 40. Global Myostatin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Myostatin Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Myostatin Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Myostatin Sales Value by Region (2020-2025) & (%)
Table 44. Global Myostatin Sales Value by Region (2026-2031) & (%)
Table 45. Global Myostatin Sales Volume by Region (kg): 2020 VS 2024 VS 2031
Table 46. Global Myostatin Sales Volume by Region (2020-2025) & (kg)
Table 47. Global Myostatin Sales Volume by Region (2026-2031) & (kg)
Table 48. Global Myostatin Sales Volume by Region (2020-2025) & (%)
Table 49. Global Myostatin Sales Volume by Region (2026-2031) & (%)
Table 50. Global Myostatin Average Price by Region (2020-2025) & (US$/kg)
Table 51. Global Myostatin Average Price by Region (2026-2031) & (US$/kg)
Table 52. Key Countries/Regions Myostatin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Myostatin Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Myostatin Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Myostatin Sales Volume, (2020-2025) & (kg)
Table 56. Key Countries/Regions Myostatin Sales Volume, (2026-2031) & (kg)
Table 57. Bio-Techne Company Information
Table 58. Bio-Techne Introduction and Business Overview
Table 59. Bio-Techne Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 60. Bio-Techne Myostatin Product Offerings
Table 61. Bio-Techne Recent Development
Table 62. Prospec Company Information
Table 63. Prospec Introduction and Business Overview
Table 64. Prospec Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 65. Prospec Myostatin Product Offerings
Table 66. Prospec Recent Development
Table 67. NeoScientific Company Information
Table 68. NeoScientific Introduction and Business Overview
Table 69. NeoScientific Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 70. NeoScientific Myostatin Product Offerings
Table 71. NeoScientific Recent Development
Table 72. FUJIFILM Irvine Scientific Company Information
Table 73. FUJIFILM Irvine Scientific Introduction and Business Overview
Table 74. FUJIFILM Irvine Scientific Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. FUJIFILM Irvine Scientific Myostatin Product Offerings
Table 76. FUJIFILM Irvine Scientific Recent Development
Table 77. R&D Systems Company Information
Table 78. R&D Systems Introduction and Business Overview
Table 79. R&D Systems Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 80. R&D Systems Myostatin Product Offerings
Table 81. R&D Systems Recent Development
Table 82. Beta Lifescience Company Information
Table 83. Beta Lifescience Introduction and Business Overview
Table 84. Beta Lifescience Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 85. Beta Lifescience Myostatin Product Offerings
Table 86. Beta Lifescience Recent Development
Table 87. ACROBiosystems Company Information
Table 88. ACROBiosystems Introduction and Business Overview
Table 89. ACROBiosystems Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 90. ACROBiosystems Myostatin Product Offerings
Table 91. ACROBiosystems Recent Development
Table 92. Biohaven Company Information
Table 93. Biohaven Introduction and Business Overview
Table 94. Biohaven Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 95. Biohaven Myostatin Product Offerings
Table 96. Biohaven Recent Development
Table 97. RayBiotech Company Information
Table 98. RayBiotech Introduction and Business Overview
Table 99. RayBiotech Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 100. RayBiotech Myostatin Product Offerings
Table 101. RayBiotech Recent Development
Table 102. Sino Biological Company Information
Table 103. Sino Biological Introduction and Business Overview
Table 104. Sino Biological Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 105. Sino Biological Myostatin Product Offerings
Table 106. Sino Biological Recent Development
Table 107. BioVendor Company Information
Table 108. BioVendor Introduction and Business Overview
Table 109. BioVendor Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 110. BioVendor Myostatin Product Offerings
Table 111. BioVendor Recent Development
Table 112. Cell Guidance Systems Company Information
Table 113. Cell Guidance Systems Introduction and Business Overview
Table 114. Cell Guidance Systems Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 115. Cell Guidance Systems Myostatin Product Offerings
Table 116. Cell Guidance Systems Recent Development
Table 117. MerckMillipore Company Information
Table 118. MerckMillipore Introduction and Business Overview
Table 119. MerckMillipore Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 120. MerckMillipore Myostatin Product Offerings
Table 121. MerckMillipore Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Myostatin Downstream Customers
Table 125. Myostatin Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Myostatin Product Picture
Figure 2. Global Myostatin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Myostatin Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Myostatin Sales Volume (2020-2031) & (kg)
Figure 5. Global Myostatin Sales Price (2020-2031) & (US$/kg)
Figure 6. Myostatin Report Years Considered
Figure 7. Global Myostatin Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Myostatin Players Sales Volume Ranking (2024) & (kg)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Myostatin Revenue in 2024
Figure 10. Myostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Active Picture
Figure 12. Inactive Picture
Figure 13. Global Myostatin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Myostatin Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Myostatin Sales Volume by Type (2020 VS 2024 VS 2031) & (kg)
Figure 16. Global Myostatin Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Myostatin Price by Type (2020-2031) & (US$/kg)
Figure 18. Product Picture of Gene Therapy
Figure 19. Product Picture of Basic Scientific Research
Figure 20. Product Picture of Treating Muscular Dystrophy
Figure 21. Product Picture of Others
Figure 22. Global Myostatin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Myostatin Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Myostatin Sales Volume by Application (2020 VS 2024 VS 2031) & (kg)
Figure 25. Global Myostatin Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Myostatin Price by Application (2020-2031) & (US$/kg)
Figure 27. North America Myostatin Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Myostatin Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Myostatin Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Myostatin Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Myostatin Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Myostatin Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Myostatin Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Myostatin Sales Volume (%), (2020-2031)
Figure 39. United States Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Myostatin Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Myostatin Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Myostatin Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Myostatin Sales Value by Application (%), 2024 VS 2031
Figure 45. China Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Myostatin Sales Value by Type (%), 2024 VS 2031
Figure 47. China Myostatin Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Myostatin Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Myostatin Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Myostatin Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Myostatin Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Myostatin Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Myostatin Sales Value by Application (%), 2024 VS 2031
Figure 57. India Myostatin Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Myostatin Sales Value by Type (%), 2024 VS 2031
Figure 59. India Myostatin Sales Value by Application (%), 2024 VS 2031
Figure 60. Myostatin Industrial Chain
Figure 61. Myostatin Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Myostatin market?
The top companies in the global Myostatin market are Bio-Techne、Prospec、NeoScientific.
Related Reports
Global Myostatin Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Myostatin market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 163
USD 4900.00
(Single User License)
Global Myostatin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Myostatin market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 96
USD 4250.00
(Single User License)
Myostatin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Myostatin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 126
USD 3950.00
(Single User License)
Global Myostatin Market Research Report 2026
The global Myostatin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 145
USD 2900.00
(Single User License)
Global Myostatin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Myostatin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 169
USD 4900.00
(Single User License)
Global Myostatin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Myostatin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 97
USD 4250.00
(Single User License)
Global Myostatin Market Research Report 2025
The global market for Myostatin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 104
USD 2900.00
(Single User License)
Global Myostatin Market Research Report 2024
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published Date: 2024-08-24
Pages: 104
USD 2900.00
(Single User License)
Global and United States Myostatin Market Report & Forecast 2024-2030
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published Date: 2024-08-24
Pages: 124
USD 4350.00
(Single User License)
Global Myostatin Market Insights, Forecast to 2030
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published Date: 2024-08-24
Pages: 166
USD 4900.00
(Single User License)
Global Myostatin Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Myostatin market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 163
USD 4900.00 (Single User License)Global Myostatin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Myostatin market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 96
USD 4250.00 (Single User License)Myostatin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Myostatin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 126
USD 3950.00 (Single User License)Global Myostatin Market Research Report 2026
The global Myostatin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 145
USD 2900.00 (Single User License)Global Myostatin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Myostatin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 169
USD 4900.00 (Single User License)Global Myostatin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Myostatin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 97
USD 4250.00 (Single User License)Global Myostatin Market Research Report 2025
The global market for Myostatin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 104
USD 2900.00 (Single User License)Global Myostatin Market Research Report 2024
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published: 2024-08-24
Pages: 104
USD 2900.00 (Single User License)Global and United States Myostatin Market Report & Forecast 2024-2030
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published: 2024-08-24
Pages: 124
USD 4350.00 (Single User License)Global Myostatin Market Insights, Forecast to 2030
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published: 2024-08-24
Pages: 166
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now